Pulse Biosciences
PLSE
49.09
-0.66
-1.33%
Pulse Biosciences
US · PLSE
#2388 by market cap
Listed 2016
49.09
-0.66
-1.33%
Live - 5344 symbols - heartbeat 130s ago
· 2026-10-08 08:06
Pre-market
48.85
-0.49%
After-hours
49.09
0.00%
- Market cap
- 3.50B
- P/E (TTM)i
- -41.96
- P/Bi
- 35.19
- EPSi
- -1.08
- Div yieldi
- 0.00%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on PLSE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/8/10
-
Needham Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $58Market Newswire · 2026/8/17
-
BTIG Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $70Market Newswire · 2026/9/23
-
Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73Market Newswire · 2026/9/9
-
Rating change
Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22Market Newswire · 2025/7/8
-
Rating change
Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22Market Newswire · 2025/11/6
-
CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $43Market Newswire · 2026/8/12
-
Rating change
Mizuho Securities Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $25Market Newswire · 2026/1/30
-
Rating change
Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/4/13
-
Rating change
Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2026/7/28
-
Rating change
Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2026/2/6
-
Rating change
Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2026/2/20
-
Rating change
CCORF Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $32Market Newswire · 2026/6/4
-
Rating change
CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $43Market Newswire · 2026/8/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:06:51 · For reference only, not investment advice and not tailored to your situation.